Navigation Links
Gene therapy inhibits epilepsy in animals

For the first time, researchers have inhibited the development of epilepsy after a brain insult in animals. By using gene therapy to modify signaling pathways in the brain, neurology researchers found that they could significantly reduce the development of epileptic seizures in rats.

"We have shown that there is a window to intervene after a brain insult to reduce the risk that epilepsy will develop," said one of the lead researchers, Amy R. Brooks-Kayal, M.D., a pediatric neurologist at The Children's Hospital of Philadelphia and associate professor of Neurology and Pediatrics at the University of Pennsylvania School of Medicine. "This provides a 'proof of concept' that altering specific signaling pathways in nerve cells after a brain insult or injury could provide a scientific basis for treating patients to prevent epilepsy."

Dr. Brooks-Kayal and Shelley J. Russek, Ph.D., of Boston University School of Medicine were senior authors of the study in the Nov. 1 Journal of Neuroscience.

Working in a portion of the brain called the dentate gyrus, the researchers focused on one type of cell receptor, type A receptors, for the neurotransmitter gamma-aminobutyric acid (GABA). When GABA(A) receptors are activated, they inhibit the repetitive, excessive firing of brain cells that characterizes a seizure. Seizures are thought to occur, at least in part, because of an imbalance between two types of neurotransmitters: the glutamate system, which stimulates neurons to fire, and the GABA system, which inhibits that brain activity.

GABA's inhibitory role is considered particularly important in the dentate gyrus because the dentate gyrus acts as a gateway for brain activity into the hippocampus, an area that is critical to generating seizures in temporal lobe epilepsy, the most common type of epilepsy in children and adults.

GABA(A) receptors are made up of five subunits--proteins that play important roles in brain development and in cont
'"/>

Source:Children's Hospital of Philadelphia


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors

Post Your Comments:
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
(Date:11/23/2009)...provides "incontrovertible evidence" that the volc...ra about 73,000 years ago deforested much of centr...earchers report. , The volcano ejected an estima...e, leaving a crater (now the world,s largest volca...eters wide. Ash from the event has been found in I...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 1Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 3Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 4New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 1New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 1Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 3Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 4
...st clinical evidence that gene therapy reduces sym...portant milestone for this promising treatment whi...ed in the February issue of the journal Human Gen...atients with severe rheumatoid arthritis conducted...ael Deaconess Medical Center (BIDMC). , Original...
...globe, the demand for water is increasing with the...reas are requiring more water for drinking, sanita...n water supplies. In addition, depleting ground wa...hange have led to an increased importance for the ...ent water pollution, and efficiently allocate wate...
...thousands of lives a year, University of Utah Scho... vessel disorder leading to unpredictable, sometim... or other problems is treatable with the same stat...igh cholesterol. , If the results of a study in m...atins could provide a safe, inexpensive treatment ...
Other Biology News:Gene therapy demonstrates benefit in patients with rheumatoid arthritis 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 3How to move agriculture forward with limited water 2Statins may treat blood vessel disorder that can lead to fatal strokes 2Statins may treat blood vessel disorder that can lead to fatal strokes 3
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstC...rmaceutical company focused on developing and comm...nced today that Anthony DiTonno, President and Chi...he 21st Annual Piper Jaffray Health Care Conferenc...alace Hotel in New York, New York. ,, Mr. DiTo...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNews...), formerly Calotto Capital Inc., a leading provid...he stem cell research and fertility clinic markets... for the third quarter ended September 30, 2009. ,...46 million compared with $1.43 million in Q3 2008,...
(Date:11/24/2009)... Program Connects Customers with Par...lected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for ...eparation, today announced its new global partner ...ts for DNA Genotek,s partner community and is desi...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...t. 15 Symmetry Medical Inc.,(NYSE: SMA ), a lead...,orthopedic device industry and other medical mark...t and Chief Executive Officer, is scheduled to,pre... The Grand Hyatt New,York in New York City on Thur...e Web cast of the presentation will be available o...
... Sept. 15 Assay Designs and the Spinal,Muscular A...nce a,collaborative agreement for development of r... protein to expedite drug discovery and developmen...eading genetic cause of,mortality in infants and t...ve been selected by the SMA Foundation, and to hel...
...5 Enobia Pharma, an emerging biotech,company focu...one,disorders, presented pre-clinical data demonst...or hypophosphatasia appears to heal bones that,hav...arlier pre-clinical,data showed that ERT with Enob...vival and prevents bone hypomineralization associa...
Other Biology Technology:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: